Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure
This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 1996-10, Vol.78 (8), p.890-895 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 895 |
---|---|
container_issue | 8 |
container_start_page | 890 |
container_title | The American journal of cardiology |
container_volume | 78 |
creator | Konstam, Varda Salem, Deeb Pouleur, Hubert Kostis, John Gorkin, Larry Shumaker, Sally Mottard, Isabelle Woods, Pat Konstam, Marvin A. Yusuf, Salim |
description | This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of |
doi_str_mv | 10.1016/S0002-9149(96)00463-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_230374251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914996004638</els_id><sourcerecordid>10415974</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</originalsourceid><addsrcrecordid>eNqFkF1rFDEUhoMouFZ_ghDECwsdzfdMrsQu1hW2WFHxMpzNnGjKOFmTbLH99Wa7pbe9Cu_hOR95CHnJ2VvOuHn3jTEmOsuVfWPNMWPKyG54RBZ86G3HLZePyeIeeUqelXLZIufaLMi_Uyg4xRnp1x1MsV7TFOg6BqRQKNCLjGP0NeV9-TzlemBgHukqlW3c5xuoMc00zlSfMKHpRcs410J_xvqbLtP8C0uNV0hXCLnSM4jTLuNz8iTAVPDF3XtEfpx9_L5cdesvnz4vP6w7r7iunRyU2Qyb0fZcgOw1iI1S3gaQZsRBGjRWSAg8jCIYlEwqxfteoNB60wpWHpFXh7nbnP7u2iXuMu3y3FY60fBeCc0bpA-Qz6mUjMFtc_wD-dpx5vaO3a1jtxforHG3jt3Q-l7fDYfiYQoZZh_LfbMUuhdaNuz9AcP20auI2RXfFPnmNqOvbkzxgUX_AfVhj1E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230374251</pqid></control><display><type>article</type><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><source>Elsevier ScienceDirect Journals</source><creator>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim</creator><creatorcontrib>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim ; SOLVD Investigators ; </creatorcontrib><description><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status.
(Am J Cardiol 1996;78:890–895)]]></description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(96)00463-8</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular disease ; Health ; Heart ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Medical sciences ; Mortality ; Quality of life</subject><ispartof>The American journal of cardiology, 1996-10, Vol.78 (8), p.890-895</ispartof><rights>1996 Excerpta Medica Inc.</rights><rights>1996 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Oct 15, 1996</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</citedby><cites>FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914996004638$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3257253$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Konstam, Varda</creatorcontrib><creatorcontrib>Salem, Deeb</creatorcontrib><creatorcontrib>Pouleur, Hubert</creatorcontrib><creatorcontrib>Kostis, John</creatorcontrib><creatorcontrib>Gorkin, Larry</creatorcontrib><creatorcontrib>Shumaker, Sally</creatorcontrib><creatorcontrib>Mottard, Isabelle</creatorcontrib><creatorcontrib>Woods, Pat</creatorcontrib><creatorcontrib>Konstam, Marvin A.</creatorcontrib><creatorcontrib>Yusuf, Salim</creatorcontrib><creatorcontrib>SOLVD Investigators</creatorcontrib><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><title>The American journal of cardiology</title><description><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status.
(Am J Cardiol 1996;78:890–895)]]></description><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular disease</subject><subject>Health</subject><subject>Heart</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Quality of life</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkF1rFDEUhoMouFZ_ghDECwsdzfdMrsQu1hW2WFHxMpzNnGjKOFmTbLH99Wa7pbe9Cu_hOR95CHnJ2VvOuHn3jTEmOsuVfWPNMWPKyG54RBZ86G3HLZePyeIeeUqelXLZIufaLMi_Uyg4xRnp1x1MsV7TFOg6BqRQKNCLjGP0NeV9-TzlemBgHukqlW3c5xuoMc00zlSfMKHpRcs410J_xvqbLtP8C0uNV0hXCLnSM4jTLuNz8iTAVPDF3XtEfpx9_L5cdesvnz4vP6w7r7iunRyU2Qyb0fZcgOw1iI1S3gaQZsRBGjRWSAg8jCIYlEwqxfteoNB60wpWHpFXh7nbnP7u2iXuMu3y3FY60fBeCc0bpA-Qz6mUjMFtc_wD-dpx5vaO3a1jtxforHG3jt3Q-l7fDYfiYQoZZh_LfbMUuhdaNuz9AcP20auI2RXfFPnmNqOvbkzxgUX_AfVhj1E</recordid><startdate>19961015</startdate><enddate>19961015</enddate><creator>Konstam, Varda</creator><creator>Salem, Deeb</creator><creator>Pouleur, Hubert</creator><creator>Kostis, John</creator><creator>Gorkin, Larry</creator><creator>Shumaker, Sally</creator><creator>Mottard, Isabelle</creator><creator>Woods, Pat</creator><creator>Konstam, Marvin A.</creator><creator>Yusuf, Salim</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>19961015</creationdate><title>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</title><author>Konstam, Varda ; Salem, Deeb ; Pouleur, Hubert ; Kostis, John ; Gorkin, Larry ; Shumaker, Sally ; Mottard, Isabelle ; Woods, Pat ; Konstam, Marvin A. ; Yusuf, Salim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3846b8bd9712a375a2b44c9fa36de836e6923af1fd2f6e303441772e255bf6e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular disease</topic><topic>Health</topic><topic>Heart</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konstam, Varda</creatorcontrib><creatorcontrib>Salem, Deeb</creatorcontrib><creatorcontrib>Pouleur, Hubert</creatorcontrib><creatorcontrib>Kostis, John</creatorcontrib><creatorcontrib>Gorkin, Larry</creatorcontrib><creatorcontrib>Shumaker, Sally</creatorcontrib><creatorcontrib>Mottard, Isabelle</creatorcontrib><creatorcontrib>Woods, Pat</creatorcontrib><creatorcontrib>Konstam, Marvin A.</creatorcontrib><creatorcontrib>Yusuf, Salim</creatorcontrib><creatorcontrib>SOLVD Investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konstam, Varda</au><au>Salem, Deeb</au><au>Pouleur, Hubert</au><au>Kostis, John</au><au>Gorkin, Larry</au><au>Shumaker, Sally</au><au>Mottard, Isabelle</au><au>Woods, Pat</au><au>Konstam, Marvin A.</au><au>Yusuf, Salim</au><aucorp>SOLVD Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure</atitle><jtitle>The American journal of cardiology</jtitle><date>1996-10-15</date><risdate>1996</risdate><volume>78</volume><issue>8</issue><spage>890</spage><epage>895</epage><pages>890-895</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract><![CDATA[This study examined the independent relation of health-related quality of life (HRQL) to mortality and congestive heart failure (CHF)-related hospitalizations in patients with an ejection fraction of <0.35 followed for a mean of 36.5 months. A brief HRQL questionnaire was administered at baseline to patients randomized to placebo or enalapril in the Studies of Left Ventricular Dysfunction (SOLVD) trial. Participants had an ejection fraction of <0.35 and either symptomatic CHF (treatment trial, n = 2,465) or asymptomatic CHF (prevention trial, n = 2,560). Baseline assessment of HRQL predicted mortality and CHF-related hospitalizations in symptomatic and asymptomatic patients randomized to enalapril and placebo treatment. Domains that were the stronger univariate predictors of mortality and CHF-related hospitalizations were activities of daily living (relative risk [RR] for mortality: 1.163, p <0.000; for hospitalization: 1.215, p <0.000), general health (RR for mortality: 1.205, p <0.000; for hospitalization: 1.188, p <0.000), and social functioning (RR for mortality 1.098, p <0.000; for hospitalization: RR 1.156, p <0.000). In the multivariate model, activities of daily living (RR for mortality 1.41, p <0.000; for hospitalization: RR 1.43, p <0.002), general health (RR for mortality 1.21, p <0.000; for hospitalization RR 1.16, p <0.013) and heart failure symptoms (RR for mortality 1.02, p <0.025; for hospitalization RR 1.03, p <0.004) were found to be independent risk factors. HRQL independently predicted mortality and CHF-related hospitalizations after adjustment for ejection fraction, age, treatment, and New York Heart Association classification in patients with an ejection fraction of <0.35, randomized to enalapril and placebo treatment. HRQL provides additional clinical information regarding disease course and outcome that is not captured by traditional indexes of clinical status.
(Am J Cardiol 1996;78:890–895)]]></abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><doi>10.1016/S0002-9149(96)00463-8</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 1996-10, Vol.78 (8), p.890-895 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_journals_230374251 |
source | Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Cardiology. Vascular system Cardiovascular disease Health Heart Heart failure, cardiogenic pulmonary edema, cardiac enlargement Medical sciences Mortality Quality of life |
title | Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T10%3A23%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Baseline%20Quality%20of%20Life%20as%20a%20Predictor%20of%20Mortality%20and%20Hospitalization%20in%205,025%20Patients%20With%20Congestive%20Heart%20Failure&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Konstam,%20Varda&rft.aucorp=SOLVD%20Investigators&rft.date=1996-10-15&rft.volume=78&rft.issue=8&rft.spage=890&rft.epage=895&rft.pages=890-895&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(96)00463-8&rft_dat=%3Cproquest_cross%3E10415974%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230374251&rft_id=info:pmid/&rft_els_id=S0002914996004638&rfr_iscdi=true |